Results 91 to 100 of about 37,897 (253)

Intoxication after Extreme Oral Overdose of Quetiapine to Attempt Suicide: Pharmacological Concerns of Side Effects

open access: yesCase Reports in Medicine, 2009
Quetiapine is an atypical antipsychotic approved for the treatment of patients with psychotic disorders. Since approvement several case reports about intoxication with quetiapine were linked mainly with tachycardia, QTc-prolongation, somnolence, and ...
C. Müller, H. Reuter, C. Dohmen
doaj   +1 more source

Distinct Gut Microbiota Profiles Reflect Severity in Chronic Insomnia Disorder

open access: yesBrain and Behavior, Volume 16, Issue 1, January 2026.
The authors used 16S rRNA sequencing and PICRUSt2 analysis to explore the link between sleep quality and gut microbiota in chronic insomnia disorder (CID) patients. Those with more severe sleep disturbances exhibited pronounced gut microbiota dysbiosis (structural/functional alterations).
Yaxi Liu   +8 more
wiley   +1 more source

Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders

open access: yesNeuropsychiatric Disease and Treatment, 2012
Nizar El-KhaliliAlpine Clinic, Lafayette, IN, USAAbstract: The atypical antipsychotic quetiapine fumarate is available both as an immediate release (IR) and as an extended release (XR) formulation allowing flexibility of dosing for individual patients ...
El-Khalili N
doaj  

Ketamine Combined With Psychotherapy as a Treatment for Resistant Depression in a Public European Hospital

open access: yesBrain and Behavior, Volume 16, Issue 1, January 2026.
This retrospective study evaluated ketamine infusions combined with psychotherapy in nine patients with treatment‐resistant depression at a general hospital. After eight weeks, all participants improved, with PHQ‐9 scores shifting from severe to moderate. Overall, 44% responded to treatment, and among those with suicidal ideation, more than half showed
Filipa Alves da Silva   +6 more
wiley   +1 more source

Exploring Adjunctive Novel Therapeutic Approach of KarXT (Xanomeline‐Trospium Chloride) for Managing Psychotic Symptoms in Patients With Schizophrenia and Alzheimer's Disease

open access: yesBrain and Behavior, Volume 16, Issue 1, January 2026.
An overview of the mechanism of action, clinical trials, and classical findings of KarXT for the management of psychotic symptoms in patients with schizophrenia and alzheimer's disease. ABSTRACT Background Acute psychotic symptoms like delusions and hallucinations are of major concern while treating patients with schizophrenia and alzheimer's psychosis,
Ashir Kanwal   +7 more
wiley   +1 more source

Three Challenging Cases of Autoimmune Encephalitis: A Case‐Series and a Review of the Literature

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT This manuscript highlights the importance of considering autoimmune encephalitis in patients presenting with multisystem symptoms that cannot be explained by a single neurological condition. Early inclusion of autoimmune encephalitis in the differential diagnosis can help avoid unnecessary treatments and reduce overall healthcare costs.
Mohammad Ali Bahramy   +2 more
wiley   +1 more source

Two cases of priapism associated with Quetiapine

open access: yesPsychiatry and Clinical Psychopharmacology, 2018
Priapism is a painful, prolonged erection that occurs without any sexual stimulation. It is an emergency that may lead impotence, urinary retention, and gangrene as long-term devastating consequences.
Özge Şahmelikoğlu Onur   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy